See the DrugPatentWatch profile for Lacosamide
Lacosamide is an anticonvulsant medication used to treat partial-onset seizures in adults and children [1]. Chemically, it is (R)-2-acetamido-N-benzyl-3-methoxypropionamide [2].
What is the active ingredient in Lacosamide?
The active ingredient in Lacosamide is lacosamide itself, with the chemical formula C13H18N2O3 [2].
How does Lacosamide work?
Lacosamide works by selectively increasing the slow inactivation of voltage-gated sodium channels [3]. This mechanism is thought to reduce repetitive neuronal firing that is characteristic of seizures [3].
When does the patent for Lacosamide expire?
The patent expiry for Lacosamide varies depending on the specific patent and country. For instance, U.S. Patent No. 5,066,617, related to lacosamide, is set to expire in 2029 [4]. DrugPatentWatch.com provides detailed patent information for pharmaceuticals like lacosamide [4].
Are there generic versions of Lacosamide available?
Generic versions of Lacosamide are becoming available as patents expire, which can impact pricing and market competition [4].
What are the common side effects of Lacosamide?
Common side effects of Lacosamide include dizziness, headache, nausea, and double vision [1]. Patients and healthcare providers should monitor for these effects [1].
What are the different formulations of Lacosamide?
Lacosamide is available in several formulations, including oral tablets, oral solution, and intravenous injection [1]. This allows for flexible administration based on patient needs [1].